Découvrez-nous

1er Écosystème Digital 100% dédié au secteur de la Beauté !

2 Portails Média
7 Plateformes dédiées
1 Solution Marketing Unique

Accès Membre 100% GRATUIT

Hologic’s Cynosure Division Signs Agreement With Porter Instrument For Exclusive Distribution Of Nitrous Oxide And Oxygen System In The Beauty Market

Hologic’s Cynosure Division Signs Agreement With Porter Instrument For Exclusive Distribution Of Nitrous Oxide And Oxygen System In The Beauty Market
Hologic, Inc. announced the signing of an agreement between its Cynosure Division and Porter Instrument, a division of Parker Hannifin Corporation, for distribution rights in the United States and Canada of the nitrous oxide and oxygen system from Porter Instrument, Nitronox ™. Cynosure is the first medical aesthetic manufacturer to offer a nitrous oxide and oxygen system to its customers.

Nitronox is a nitrogen oxide and oxygen self-administration system providing a quick-acting inhaled pain reliever that helps patients manage their potential discomfort and anxiety while remaining alert and aware during their cosmetic procedures. Nitrous oxide and oxygen have been used safely and effectively for over 100 years for pain management. More recently, the non-invasive delivery system for Nitronox devices has developed a solid track record in labor and delivery, as well as in ambulatory medical settings.

“We are very pleased to combine Porter Instrument’s long-standing leadership and innovation in the nitrogen oxide category with our market leading medical aesthetic offerings,” said Kevin. Thornal, president of Cynosure’s Hologic division. “This agreement allows us to offer our current and future customers a distinct competitive advantage: an unrivaled and more comfortable patient experience.”

On the agreement, Jay Reidy, general manager of Parker precision fluidics division, said, “We are delighted to partner with Cynosure, a market leader in medical aesthetics. Our gas distribution products are an ideal solution for the management of pain and anxiety of patients during various procedures. Combined with the strength of Cynosure’s sales and service teams, it will be a winning combination for doctors and patients. ”

Hologic anticipates that Nitronox will be used in addition to hair removal, tattoo removal, body contouring and skin revitalization procedures.

About Hologic, Inc.

Hologic, Inc. is an innovative medical technology company focused primarily on improving health and well-being. be women through early detection and treatment. For more information on Hologic, visit www.hologic.com .

Hologic and Cynosure are trademarks and / or registered trademarks of Hologic, Inc. and / or its affiliates in the United States and / or other countries.

Forward-looking statements

This press release may contain forward-looking information that involves risks and uncertainties, including statements regarding the use of Hologic products. There is no guarantee that these products will benefit from the advantages described in this document or that these advantages will be reproduced in a particular way with regard to a given patient, since the real effect of the use of the products can only be determined on a case-by-case basis. . case base. In addition, there is no guarantee that these products will achieve commercial success or reach the expected level of sales. Hologic expressly disclaims any obligation or obligation to publicly disclose any update or revision of these statements presented in this document to reflect any change in expectations or any change in the events, conditions or circumstances on which these data or statements are based .

Beaute Particuliers Demander Informations 2

Related posts